A Trial on Different Dosages of Vitamin D in Preterm Infants With Late-onset Sepsis
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
This is a randomized controlled trial (RCT) to evaluate the influence of different doses of
vitamin D3 (800 IU/d versus 400 IU/d), on serum levels of interleukin (IL)-6, TNF-alpha and
C- reactive (CRP) in premature infants with clinical evidence of late-onset sepsis and to
assess its influence on clinical outcomes of these infants.
Phase:
Phase 1
Details
Lead Sponsor:
Mansoura University Children Hospital
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins